| 000 | 01401 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516230401.0 | ||
| 264 | 0 | _c20151103 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/srep06104 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeng, Liang | |
| 245 | 0 | 0 |
_aEfficacy analysis of tyrosine kinase inhibitors on rare non-small cell lung cancer patients harboring complex EGFR mutations. _h[electronic resource] |
| 260 |
_bScientific reports _cAug 2014 |
||
| 300 |
_a6104 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma, Bronchiolo-Alveolar _xdrug therapy |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aErlotinib Hydrochloride |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aQuinazolines _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aSong, Zhi-Gang | |
| 700 | 1 | _aJiao, Shun-Chang | |
| 773 | 0 |
_tScientific reports _gvol. 4 _gp. 6104 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep06104 _zAvailable from publisher's website |
| 999 |
_c24105162 _d24105162 |
||